Back to search

Peptide record

TPDB42897

2D2(Q44-Y51) Anticancer standard
18 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB42897
2D2(Q44-Y51)
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 18-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
RRRRRRRRGGQGLTIYFY
Physicochemical Analysis
C102H171N43O23
ANDCEHKMPSWV
R
2367.75
12.62
8
0
5
+8
3.35
-1.828
43.33
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
2980
125.86
4
Residue Composition
number
0
A
8
R
0
N
0
D
0
C
0
E
1
Q
3
G
0
H
1
I
1
L
0
K
0
M
1
F
0
P
0
S
1
T
0
W
2
Y
0
V
Amino Acid Distribution
A: 0 R: 8 N: 0 D: 0 C: 0 E: 0 Q: 1 G: 3 H: 0 I: 1 L: 1 K: 0 M: 0 F: 1 P: 0 S: 0 T: 1 W: 0 Y: 2 V: 0
Chemical Descriptors
18
C102H171N43O23
2367.75
12.62
+8
3.35
-1.828
Free
L
Linear
Free
Anticancer
STAP-2 PH domain–derived peptide
Evidence Records 1 records
Evidence 1 Activity

Activity

Graph figure 1-C
Anticancer

Target

Liver Cancer
DU-145
Liver

Assay & Model

CellTiter-Glo assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.